American Century Companies Inc. Purchases 366,653 Shares of Puma Biotechnology, Inc. - MarketBeat

PBYI Stock  USD 3.39  0.16  4.95%   
Under 58% of all Puma Biotechnology's traders are looking to take a long position. The analysis of the overall investor sentiment regarding Puma Biotechnology suggests that some traders are interested. Puma Biotechnology's investing sentiment shows overall attitude of investors towards Puma Biotechnology.
  
American Century Companies Inc. Purchases 366,653 Shares of Puma Biotechnology, Inc. MarketBeat

Read at news.google.com
Google News at Macroaxis
  

Puma Biotechnology Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Puma Biotechnology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Puma Biotechnology Fundamental Analysis

We analyze Puma Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Puma Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Puma Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Per Share

Cash Per Share Comparative Analysis

Puma Biotechnology is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Puma Biotechnology Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Puma Biotechnology stock to make a market-neutral strategy. Peer analysis of Puma Biotechnology could also be used in its relative valuation, which is a method of valuing Puma Biotechnology by comparing valuation metrics with similar companies.

Peers

Puma Biotechnology Related Equities

HEPAHepion Pharmaceuticals   4.69   
0%
100.0%
ARVNArvinas   2.85   
0%
60.0%
HRTXHeron Therapeuti   2.59   
0%
55.0%
TSVT2Seventy Bio   0.76   
0%
16.0%
CRNXCrinetics Pharmaceuticals   0.81   
17.0%
0%
IOVAIovance Biotherapeutics   0.85   
18.0%
0%
MDGLMadrigal Pharmaceuticals   0.98   
20.0%
0%
RAREUltragenyx   1.04   
22.0%
0%
KURAKura Oncology   1.16   
24.0%
0%
RVMDRevolution Medicines   1.25   
26.0%
0%
MGNXMacroGenics   1.37   
29.0%
0%
PTCTPTC Therapeutics   2.73   
58.0%
0%
VKTXViking Therapeutics   2.88   
61.0%
0%
CHRSCoherus BioSciences   3.17   
67.0%
0%
SRPTSarepta Therapeutics   3.33   
71.0%
0%
LRMRLarimar Therapeutics   4.67   
99.0%
0%

Complementary Tools for Puma Stock analysis

When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Correlations
Find global opportunities by holding instruments from different markets
Stocks Directory
Find actively traded stocks across global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
FinTech Suite
Use AI to screen and filter profitable investment opportunities